
Gastric cancer/medscape.com
Dec 25, 2024, 14:49
Akhil Santhosh: Fruquitinib with or without paclitaxel in pretreated advanced gastric cancer
Akhil Santhosh, Medical Oncology Specialist at MVR Cancer Centre and Research Institute, shared a post on X:
“FRUTIGA phase 3 RCT: Fruquitinib with or without paclitaxel in pretreated advanced ca stomach.
Median PFS 5.6m vs 2.7m in favour of the combination.
Median OS 9.6m vs 8.4, not statistically significant.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Mar 10, 2025, 09:36
Mar 10, 2025, 09:32
Mar 10, 2025, 09:12
Mar 10, 2025, 08:53
Mar 10, 2025, 08:40
Mar 10, 2025, 08:34
Mar 10, 2025, 08:32
Mar 10, 2025, 08:17